Flanders Institute for Biotechnology:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C9280)
◆英語タイトル:Flanders Institute for Biotechnology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9280
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:56
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Flanders Institute for Biotechnology (VIB) is a non-profit life sciences research institute that offers pharmaceutical, agricultural, and other industrial research programs. The institute offers research services in areas of cardiovascular medicine, bioinformatics, proteomics and systems biology, inflammation and immunity, and neurosciences, among others. It also provides research services in the areas of assay development and compound screening, sequencing and genotyping, purification and analysis, nanobodies, protein production, lab informatics, gateway services, bio imaging core, and others. VIB offers PhD program and doctoral and postdoctoral courses in life sciences. The institute provides solutions for translating scientific results into agricultural, pharmaceutical, and industrial applications. VIB is headquartered in Gent, Belgium.

Flanders Institute for Biotechnology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Flanders Institute for Biotechnology, Medical Devices Deals, 2012 to YTD 2018 10
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Confo Therapeutics Raises USD7.3 Million Financing 12
Partnerships 14
BioPontis Alliance for Rare Diseases Enters into Co-Development Agreement with VIB 14
ThromboGenics Forms Joint Venture with VIB 15
Licensing Agreements 16
Oncurious Enters into Licensing Agreement with VIB 16
AstraZeneca Enters Into Licensing Agreement with VIB and CD3 17
Equity Offering 18
Aelin Therapeutics Spin Out from K.U. Leuven, University of Leuven and Flanders Institute for Biotechnology 18
Confo Therapeutics Spin Off from VIB and Vrije Universiteit Brussel 19
Acquisition 20
Intrexon Acquires ActoGeniX 20
Flanders Institute for Biotechnology – Key Competitors 22
Flanders Institute for Biotechnology – Key Employees 23
Flanders Institute for Biotechnology – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Jun 02, 2017: New Centre for Bioassay Development and Screening (C-BIOS) launched to support early-stage drug/agro discovery 25
Government and Public Interest 26
Oct 25, 2018: Belgian researchers discover a novel method to block immunosuppression in cancer 26
Aug 30, 2018: Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy 28
Aug 24, 2018: New immunotherapy inhibits tumor growth and protects against metastases 30
Apr 06, 2018: Competitive ERC Advanced Grant awarded to Bart Lambrecht to study the role of protein crystallization in asthma 32
Mar 20, 2018: Two genes cooperate to trigger leukemia development 33
Jul 27, 2017: Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease 34
Jun 01, 2017: Scientists give tumor-fighting cells a boost in battling bone marrow 35
May 20, 2017: Wim Versees receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 36
May 04, 2017: Crucial role for XBP1 in several aspects of DC functioning and homeostasis 37
May 03, 2017: A new unexpected key player in melanoma development identified 38
Apr 20, 2017: The Baillet Latour Grant 2017 for Medical Research awarded to professor Roosmarijn Vandenbroucke (VIB-UGent) 40
Mar 23, 2017: Competitive ERC Advanced Grant awarded to Peter Carmeliet for Tumor Endothelial Cell research 41
Mar 21, 2017: PHD2 targeting overcomes breast cancer cell death upon glucose starvation 42
Mar 14, 2017: VIB: Three accomplished VIB Scientists receive ERC Consolidator grants 43
Feb 14, 2017: Researchers identify phosphorylation process vital to cancer growth 44
Feb 13, 2017: Scientists isolate new antibodies to fight human respiratory syncytial virus 46
Feb 13, 2017: Scientists isolate new antibodies to fight human respiratory syncytial virus (RSV) 47
Feb 10, 2017: Mitochondrial lipids as potential targets in early onset Parkinson’s disease 49
Product News 50
Aug 22, 2017: BioXp Genomic Workstation Makes European Debut at VIB Research Institute in Belgium 50
Aug 17, 2017: Scientists unravel role of glutamine synthetase in the spread of cancer 51
May 19, 2017: Tau prevents synaptic transmission at early stage of neurodegeneration 52
May 11, 2017: Launch of IMPRiND Consortium to investigate how aggregated proteins contribute to progression of Alzheimer’s and Parkinson’s Disease 53
Jan 20, 2017: Protein IL-33 found to drive allergic sensitivity in the neonatal lung 54
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Key Facts 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flanders Institute for Biotechnology, Deals By Therapy Area, 2012 to YTD 2018 9
Flanders Institute for Biotechnology, Medical Devices Deals, 2012 to YTD 2018 10
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Confo Therapeutics Raises USD7.3 Million Financing 12
BioPontis Alliance for Rare Diseases Enters into Co-Development Agreement with VIB 14
ThromboGenics Forms Joint Venture with VIB 15
Oncurious Enters into Licensing Agreement with VIB 16
AstraZeneca Enters Into Licensing Agreement with VIB and CD3 17
Aelin Therapeutics Spin Out from K.U. Leuven, University of Leuven and Flanders Institute for Biotechnology 18
Confo Therapeutics Spin Off from VIB and Vrije Universiteit Brussel 19
Intrexon Acquires ActoGeniX 20
Flanders Institute for Biotechnology, Key Competitors 22
Flanders Institute for Biotechnology, Key Employees 23
Flanders Institute for Biotechnology, Joint Venture 24

List of Figures
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Flanders Institute for Biotechnology, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Flanders Institute for Biotechnology:製薬・医療:M&Aディール及び事業提携情報(Flanders Institute for Biotechnology - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆